Ginkgo Bioworks Holdings (DNA) Net Equity Issued and Repurchased (2021 - 2025)

Ginkgo Bioworks Holdings (DNA) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $9.2 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $9.2 million; the trailing twelve-month figure through Dec 2025 stood at $35.2 million (up 50.83% YoY), and the FY2025 full-year result was $19.5 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased declined to $9.2 million in Q4 2025 per DNA's latest filing, from $10.3 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $15.8 million in Q4 2022 and bottomed at $7.6 million in Q3 2022.
• Historically, Net Equity Issued and Repurchased has averaged $11.6 million across 3 years, with a median of $10.3 million in 2025.
• The widest YoY moves for Net Equity Issued and Repurchased: up 49.68% in 2022, down 49.68% in 2022.
• Over 3 years, Net Equity Issued and Repurchased stood at $15.1 million in 2021, then climbed by 4.56% to $15.8 million in 2022, then plunged by 41.98% to $9.2 million in 2025.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $9.2 million, $10.3 million, and $15.8 million for Q4 2025, Q3 2025, and Q4 2022 respectively.